-
Impact of Pre-Existing and New-Onset Atrial Fibrillation on Outcomes After Transcatheter Aortic Valve ReplacementA Mentias, M Saad, S Girotra et al. -
Prognostic Value of Computed Tomography-Derived Extracellular Volume in TAVR Patients With Low-Flow Low-Gradient Aortic StenosisB Tamarappoo, D Han, D Berman et al.
-
Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVRNM Van Mieghem, M Unverdorben, the ENVISAGE-TAVI AF Investigators.
-
Empagliflozin, Health Status, and Quality of Life in Patients with Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved TrialJ Butler, G Filippatos, TJ Siddiqi et al.
-
Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Rheumatic Aortic StenosisA Mentias, M Saad ,MY Desai et al.
-
5-Year Outcomes Comparing Surgical Versus Transcatheter Aortic Valve Replacement in Patients With Chronic Kidney DiseaseS Garcia, RJ Cubeddu, RT Hahn et al.
-
Safety and Efficacy of Transcatheter Aortic Valve Replacement With Continuation of Vitamin K Antagonists or Direct Oral AnticoagulantsM Brinkert, N Mangner, S Toggweiler et al.
-
Evaluation and Management of Aortic Stenosis in Chronic Kidney Disease: A Scientific Statement From the American Heart AssociationGR Shroff , S Bangalore and On behalf of the American Heart Association Council on the Kidney in Cardiovascular Disease and Stroke Council
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
